The Pneumococcal Type 1 Pilus Genes Are Thermoregulated and Are Repressed by a Member of the Snf2 Protein Family

Journal of Bacteriology
Alan BassetRichard Malley

Abstract

InStreptococcus pneumoniae, the type 1 pilus is involved in many steps of pathogenesis, including adherence to epithelial cells, mediation of inflammation, escape from macrophages, and the formation of biofilms. The type 1 pilus genes are expressed in a bistable fashion with cells switching between "on" and "off" expression states. Bistable expression of these genes is due to their control by RlrA, a positive regulator subject to control by a positive-feedback loop. The type 1 pilus genes are also thought to be negatively regulated by a large number of repressors. Here we show that expression of the type 1 pilus genes is thermosensitive and switched off at growth temperatures below 31°C. We also report that the on expression state of the type 1 pilus genes is highly stable, a phenomenon which we show likely contributed to the erroneous identification of many proteins as negative regulators of these genes. Finally, we exploited the effect of low temperature on pilus gene expression to help identify SP_1523, an Snf2-type protein, as a novel negative regulator of the pilus genes. Our findings establish that the type 1 pilus genes are thermoregulated and are repressed by a member of the Snf2 protein family. They also refute the not...Continue Reading

References

Jul 1, 1986·The Journal of Antimicrobial Chemotherapy·R Austrian
Apr 18, 1998·The Journal of Biological Chemistry·M V Sukhodolets, D J Jin
Jun 17, 1998·The Journal of Biological Chemistry·O MuzzinK Severinov
Apr 14, 2000·The Laryngoscope·T KeckG Rettinger
Oct 27, 2001·Applied and Environmental Microbiology·C K SungD A Morrison
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Jan 4, 2003·Journal of Bacteriology·David L HavaAndrew Camilli
Feb 17, 2006·Proceedings of the National Academy of Sciences of the United States of America·M A BarocchiB Henriques-Normark
Nov 7, 2006·Journal of Bacteriology·Wouter T HendriksenTim J Mitchell
Mar 30, 2007·Journal of Clinical Microbiology·Alan BassetRichard Malley
Aug 1, 2007·Antimicrobial Agents and Chemotherapy·S V LynchA Matin
Sep 14, 2007·Molecular Microbiology·A L NelsonB Henriques-Normark
Apr 30, 2008·Infection and Immunity·Jason W RoschElaine Tuomanen
Feb 20, 2009·Molecular Microbiology·Jason W RoschElaine I Tuomanen
Sep 15, 2009·Lancet·Katherine L O'BrienUNKNOWN Hib and Pneumococcal Global Burden of Disease Study Team
Jul 7, 2011·PloS One·Gabriella De AngelisMichèle A Barocchi
Dec 13, 2012·The Journal of Biological Chemistry·Alan BassetRichard Malley

❮ Previous
Next ❯

Citations

Jul 5, 2019·Clinical Microbiology Reviews·Marianne F L van den BroekSarah Lebeer
Feb 27, 2021·Frontiers in Microbiology·Stefan Ness, Markus Hilleringmann
Feb 27, 2021·Frontiers in Microbiology·Masanobu Nakata, Bernd Kreikemeyer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.